Yun Xiao Selected Research

Monoclonal Antibodies

4/2022	Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies.
5/2014	RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun Xiao Research Topics

Disease

66	Neoplasms (Cancer) 04/2024 - 10/2008
14	Carcinogenesis 01/2023 - 10/2011
10	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2014
8	Inflammation (Inflammations) 02/2023 - 01/2013
6	Deafness (Deaf Mutism) 03/2024 - 08/2016
6	Nasopharyngeal Carcinoma 01/2024 - 01/2019
6	Fibrosis (Cirrhosis) 06/2023 - 10/2006
6	Lung Neoplasms (Lung Cancer) 05/2023 - 06/2003
6	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 07/2013
5	Pain (Aches) 10/2023 - 01/2016
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2023 - 09/2020
5	Neoplasm Metastasis (Metastasis) 05/2023 - 02/2015
5	Hearing Loss (Hearing Impairment) 01/2022 - 01/2016
4	Wounds and Injuries (Trauma) 09/2022 - 10/2016
3	Adenocarcinoma 04/2024 - 04/2011
3	Myocardial Infarction 04/2024 - 05/2015
3	Infections 12/2023 - 12/2017
3	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 05/2021
3	Lupus Nephritis 09/2023 - 09/2020
3	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 01/2013
3	Neuroinflammatory Diseases 02/2022 - 07/2020
3	Ischemic Stroke 01/2022 - 02/2019
3	Stroke (Strokes) 01/2022 - 10/2015
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
3	Triple Negative Breast Neoplasms 01/2022 - 12/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2018
3	Malignant Mesothelioma 11/2021 - 01/2017
3	Carcinoma (Carcinomatosis) 01/2020 - 11/2016
3	Adenocarcinoma of Lung 09/2019 - 04/2011
3	Prostatic Neoplasms (Prostate Cancer) 05/2018 - 10/2011
3	Heart Failure 01/2018 - 11/2012
3	Leukemia 01/2017 - 04/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2011 - 10/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 02/2019
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2022 - 01/2021
2	Multiple Sclerosis 02/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2013
2	Mesothelioma 11/2021 - 01/2017
2	Neuralgia (Stump Neuralgia) 11/2021 - 10/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2021 - 12/2017
2	Necrosis 01/2021 - 06/2014
2	Ischemia 07/2020 - 12/2013
2	Retinal Perforations 04/2020 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 01/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 07/2015

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
16	Proteins (Proteins, Gene)FDA Link 08/2023 - 04/2011
16	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2011
16	Long Noncoding RNAIBA 01/2020 - 01/2015
9	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2014
7	Messenger RNA (mRNA)IBA 11/2019 - 10/2011
6	Transfer RNA (tRNA)IBA 01/2022 - 01/2016
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2002
5	Therapeutic UsesIBA 02/2024 - 07/2015
5	AntibodiesIBA 09/2023 - 05/2014
5	Phosphotransferases (Kinase)IBA 01/2022 - 01/2010
5	Mitochondrial DNA (mtDNA)IBA 01/2022 - 08/2016
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 10/2008
4	Immunoglobulin G (IgG)IBA 09/2023 - 09/2020
4	CytokinesIBA 06/2023 - 11/2012
4	AsbestosIBA 01/2022 - 06/2012
4	Competitive Endogenous RNAIBA 09/2020 - 11/2016
3	CateninsIBA 04/2024 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 12/2022 - 07/2015
3	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2021
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 07/2020
3	PlatinumIBA 01/2021 - 01/2019
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2019 - 01/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2014 - 10/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 02/2010
2	Antinuclear AntibodiesIBA 08/2022 - 09/2020
2	Monoclonal AntibodiesIBA 04/2022 - 05/2014
2	CuprizoneIBA 02/2022 - 01/2022
2	LigandsIBA 01/2022 - 12/2011
2	Gemcitabine FDA Link 01/2022 - 01/2019
2	Propofol (Diprivan)FDA LinkGeneric 01/2022 - 01/2022
2	montelukast (Singulair)FDA Link 01/2022 - 01/2021
2	Serpentine Asbestos (Chrysotile)IBA 01/2022 - 11/2021
2	FSC 231IBA 11/2021 - 10/2021
2	Substance PIBA 11/2021 - 10/2021
2	Circular RNAIBA 01/2021 - 02/2019
2	Small Cytoplasmic RNAIBA 01/2021 - 01/2019
2	Retinaldehyde (Retinal)IBA 04/2020 - 09/2015
2	ChromatinIBA 01/2020 - 04/2002
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 09/2019

Therapy/Procedure

30	Therapeutics 04/2024 - 01/2010
9	Drug Therapy (Chemotherapy) 01/2023 - 09/2014
7	Immunotherapy 01/2023 - 12/2018
4	Vitrectomy 01/2022 - 01/2018
3	Chemoradiotherapy 02/2024 - 01/2019
3	Radiotherapy 06/2023 - 01/2021
2	Cochlear Implantation 03/2024 - 01/2020
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024 - 01/2019
2	Precision Medicine 02/2023 - 11/2019
2	Induction Chemotherapy 01/2022 - 01/2019
2	Sutures (Suture) 01/2020 - 01/2018